Skip navigation

 Login or Register | Member Centre

GlobeInvestorGOLD Canada's most comprehensive investment tool.

 
Change Symbol: Lookup Trade Now

Amgen | Headlines

  • Vol:
  • Last Trade:
Search found 68 documents NextNext
1: Amgen to Present at Lazard Capital Healthcare Conference
PR NEWSWIRE, November 16, 2009 06:06 PM

2: Amgen to Present at 18th Annual Credit Suisse Healthcare Conference
PR NEWSWIRE, November 12, 2009 09:01 AM

3: Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
PR NEWSWIRE, November 5, 2009 08:03 AM

4: Call for Applications: The Amgen Award for Science Teaching Excellence
PR NEWSWIRE, November 4, 2009 12:22 PM

5: Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints
PR NEWSWIRE, October 30, 2009 08:44 PM

6: Amgen's Third Quarter 2009 Adjusted Earnings Per Share Increased 21 Percent to $1.49
PR NEWSWIRE, October 21, 2009 04:08 PM

7: Amgen Provides Update on Status of Prolia(TM) (Denosumab) Biologics License Application (BLA) Submitted to the U.S. Food and Drug Administration (FDA)
PR NEWSWIRE, October 19, 2009 08:00 AM

8: Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting
PR NEWSWIRE, October 16, 2009 01:07 PM

9: Amgen Announces Webcast of 2009 Third Quarter Financial Results
PR NEWSWIRE, October 15, 2009 04:42 PM

10: Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorectal Cancer
PR NEWSWIRE, September 24, 2009 03:37 AM

NextNext
 

Search using one or more of the following options:

Symbol Lookup
 
 
  Search Tips
 
  * Can only be used when searching The Globe and Mail and newswires.

Back to top